Kreitzer Anatol
- SEC CIK
- 0002021238
In the past year, 3 open-market sale filings worth $2.78M and no purchases.
Current role at each company
- MPLT MapLight Therapeutics, Inc.Chief Discovery Officeras of Aug 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.78M
- 3 filings
- Net
- −$2.78M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kreitzer Anatol as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 (view filing)6:00 AM ET | Jul 15-17 | 5 daysLate | Kreitzer AnatolChief Discovery Officer | SSaleVoting Common Stock | −36.3K | $37.09 | −$1.35M | −17.2%174.9K after | 7 lots10b5-1 |
| Apr 29, 2026 (view filing) | Apr 27 | 2 days | Kreitzer AnatolChief Discovery Officer | SSaleVoting Common Stock | −45.4K | $29.66 | −$1.35M | −17.7%211.2K after | 3 lots10b5-1 |
| Apr 17, 2026 (view filing) | Apr 15 | 2 days | Kreitzer AnatolChief Discovery Officer | SSaleVoting Common Stock | −3.32K | $26.61 | −$88.2K | −1.3%256.6K after |